Navigation Links
Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Date:2/5/2008

s press release. These tables include adjustments that we can reasonably predict. Events that could cause the reconciliation to change include acquisitions and divestitures of business, goodwill and other asset impairments and sales of marketable equity securities.

The following table includes the GAAP income statement for the three months and twelve months periods ending in 2007 and 2006.

THORATEC CORPORATION

Condensed Consolidated Statement of Operations

(Unaudited)

(in thousands, except for per share data)

Three Months For the Fiscal

Ended Year Ended

December December December December

29, 2007 31, 2006 29, 2007 31, 2006

Product sales $64,082 $58,848 $234,780 $214,133

Cost of product sales 28,364 23,808 98,516 88,648

Gross profit 35,718 35,040 136,264 125,485

Operating expenses:

Selling, general and

administrative 20,092 18,459 82,044 73,687

Research and development 11,463 11,733 43,835 39,841

Amortization of purchased

intangible assets 3,143 3,134 12,582 12,055

In-process research and development - 1,120 - 1,120

Litigation - - - 447

Total operating expenses 34,698 34,446 138,461 127,150

Income (loss) from operations 1,020 594 (2,197) (1,665)

Other income and (expense):

Interest expense (927) (1,117) (4,085) (4,276)

Interest income and oth
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Thoratec Presentation at JP Morgan Conference to be Webcast
2. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
3. Thoratec Presentation at Bear Stearns Conference To Be Webcast
4. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
5. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
6. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
7. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
8. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
9. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
10. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
11. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 Natera, Inc., a leader ... published in Ultrasound in Obstetrics & Gynecology ... non-invasive prenatal test (NIPT) can identify a complete ... A study based upon data collected in ... in about 1 in 1,000 pregnancies, although other ...
(Date:5/28/2015)... NORTH BRUNSWICK, N.J. , May 28, 2015 ... that PDS0101, a cancer immunotherapy treatment targeting HPV-16, ... patients.  Currently, pre-cervical cancer is ... could offer a simple and effective non-surgical alternative. ... body,s defense mechanisms (T-cells) to recognize, target, and ...
(Date:5/28/2015)... , May 28, 2015  GenVec, Inc. (Nasdaq: ... CEO, Douglas J. Swirsky , will present a ... at 11 a.m. EDT on Thursday, June 4, 2015. ... Mr. Swirsky,s presentation will be available at the following ... available on GenVec,s website.  To access, visit www.genvec.com ...
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo ... EMR/EHR Clinical Data Integration with EDC Systems ” at ... DC on June 14th-18th. , During the presentation, Glenn ... with EDC, and will examine the value of patient ... electronic health records/electronic medical records integration. , The ...
Breaking Biology Technology:First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2GenVec To Present At The Jefferies Healthcare Conference 2Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2
... Researchers at Oregon State University have solved a quest ... the 1960s, and could form the basis of a ... online in the professional journal Advanced Materials, outlines the ... diode. "Researchers have been trying to do this ...
... of FDA inspectors; now it trains thousands of those ... team of FDA compliance experts, EduQuest is presenting the ... course for quality managers and regulatory specialists December 7-9, ... I-95, Amtrak rail lines, and the Philadelphia airport). Course ...
... NEW YORK, Oct. 29 Regenicin, Inc. ... company specializing in the development of regenerative cell therapies ... today announced that the Company,s Chief Executive Officer, Randall ... at RetailInvestorConferences.com .DATE: , November 4, 2010TIME: ...
Cached Biology Technology:Advance could change modern electronics 2Advance could change modern electronics 3Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11 2Regenicin to Present Live at RetailInvestorConferences.com on November 4th 2
(Date:5/20/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... LLC, a company engaged in biometric identification is an ... portion of the recently awarded TIES (Technical Information Engineering ... Army. 3D-ID LLC has a suite of ... and security agencies. Gino Pereira , ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/10/2015)... 11, 2015 Fingerprint Cards (FPC) has ... FPC1155 from the distributor World Peace Industrial Group (WPI), part ... Asia . Deliveries are planned to take ... by smartphone manufacturers in China . The ... revenue guidance of + 1 000 MSEK for 2015.   ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... May 15, 2008The investigational chemotherapeutic agent eribulin mesylate ... of women with locally advanced or metastatic breast ... II clinical trial. The study also suggests ... with a low incidence of Grade 3 (severe) ...
... 2008 -- There is only one place this summer where the ... and clarinet will be heard next door to advanced sonar systems; ... falls of Antarctic ice shelves. These sounds -- and ... at the Acoustics,08 Paris meeting, to be held Monday June 30 ...
... R.I. [Brown University] Imagine being paralyzed, unable to move ... five million Americans suffer from this debilitating situation. Or imagine ... of Americans are affected by these infirmities. Now imagine ... hands or arms enough to tap out an e-mail on ...
Cached Biology News:Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer 2Eribulin mesylate demonstrated anti-tumor activity in patients with advanced breast cancer 3Brown to host conference on advances in neurotechnology 2Brown to host conference on advances in neurotechnology 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
IC50: 3 ng/ml · Limit of detection: 0.9 ng/ml...
Request Info...
Biology Products: